BRIEF published on 06/11/2026 at 07:05, 11 days 12 hours ago Biosynex finalizes the sale of its molecular biology business Restructuring Transfer BIOSYNEX Molecular Biology Rapid Diagnosis
BRIEF published on 06/11/2026 at 07:05, 11 days 12 hours ago Biosynex sells its molecular biology business Strategic Growth Transfer BIOSYNEX Molecular Biology Rapid Diagnosis
BRIEF published on 05/25/2026 at 08:05, 28 days 11 hours ago BIOSYNEX is considering the sale of its Molecular Biology business Pharmaceutical Industry Strategy Transfer BIOSYNEX Molecular Biology
BRIEF published on 05/25/2026 at 08:05, 28 days 11 hours ago Biosynex sells its molecular biology business Transfer BIOSYNEX Molecular Biology Conditions Precedent Pharmaceutical Manufacturer
BRIEF published on 04/30/2026 at 18:05, 1 month 22 days ago BIOSYNEX SA: 2025 Annual Report and Outlook for 2026 EBITDA Revenue BIOSYNEX 2025 Results Outlook 2026
BRIEF published on 04/20/2026 at 18:50, 2 months 2 days ago BIOSYNEX postpones the publication of its 2025 annual accounts BIOSYNEX Backup Procedure Postponement Of Publication Health Diagnosis 2025 Annual Accounts
BRIEF published on 04/20/2026 at 18:50, 2 months 2 days ago BIOSYNEX postpones the publication of its 2025 annual accounts Financial Report Development Backup Annual Accounts BIOSYNEX
BRIEF published on 03/24/2026 at 09:02, 2 months 29 days ago BIOSYNEX SA: Extension of the observation period under safeguard Reorganization BIOSYNEX Backup Procedure Adjournment Debt Repayment Plan
BRIEF published on 03/24/2026 at 07:05, 2 months 29 days ago Renewal of the observation period for BIOSYNEX Reorganization Cost Reduction Backup BIOSYNEX Debt Repayment Plan
BRIEF published on 03/17/2026 at 18:10, 3 months 5 days ago Nathalie Roos joins the Board of Directors of BIOSYNEX Board Of Directors Governance Business Transformation BIOSYNEX Nathalie Roos
Published on 06/22/2026 at 15:58, 3 hours 29 minutes ago Metallic Minerals Closes Upsized C$10.3 Million Bought Deal LIFE Private Placement
Published on 06/22/2026 at 15:30, 3 hours 57 minutes ago NanoViricides Has Shipped NV-387 Oral Gummies Drug Product for Phase II Clinical Trial to DR Congo
Published on 06/22/2026 at 15:00, 4 hours 27 minutes ago Jaguar Health Announces Plan to Explore Strategic Alternatives Aligned with Targeted NDA Filing for Rare Disease Intestinal Failure Program
Published on 06/22/2026 at 14:01, 5 hours 26 minutes ago Worksport (NASDAQ:WKSP) Achieves 35% May Gross Margin, Lands Meyer Distribution, Targets $36M+ Revenue Run-Rate
Published on 06/22/2026 at 14:00, 5 hours 27 minutes ago Adcore Enters Strategic Partnership with TikTok as a Channel Sales Partner
Published on 06/22/2026 at 18:54, 32 minutes ago EQS-Adhoc: Brenntag SE publishes preliminary operating EBITDA for the second quarter of 2026 and increases its guidance for the financial year 2026
Published on 06/22/2026 at 18:30, 56 minutes ago Avolta awarded 10-year contract at Orlando International Airport across travel retail and F&B
Published on 06/22/2026 at 18:05, 1 hour 21 minutes ago Bybit EU Strengthens European Positioning Ahead of MiCAR Transition
Published on 06/22/2026 at 18:00, 1 hour 26 minutes ago Zendure Unveils the ZEN+ HOME AI Energy Ecosystem at Intersolar 2026
Published on 06/22/2026 at 18:00, 1 hour 27 minutes ago GUILLEMOT CORPORATION: STATEMENT REGARDING THE PASSING OF Mr. CLAUDE GUILLEMOT, CHAIRMAN OF GUILLEMOT CORPORATION GROUP
Published on 06/22/2026 at 08:30, 10 hours 57 minutes ago Eiffage enters into exclusive negotiations with Atlas Arteria for the possible acquisition of the Warnow Tunnel concession in Rostock, Germany
